Announcements Trials
Browse Landscape

Status

Recruiting 14Completed 6Terminated 3Active not recruiting 2Unknown 1Suspended 1Not yet recruiting 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1NET 1Endocrine 1

Conditions

Sarcoma 6Prostatic Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Osteosarcoma 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Stomach Neoplasms 1Sarcoma, Synovial 1Primary Myelofibrosis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liposarcoma, Myxoid 1Liposarcoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Hodgkin Disease 1Glioblastoma 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Fibrosarcoma 1Endometrial Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Neuroendocrine Tumors × Sarcoma × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡